Ad is loading...
SXTC
Price
$0.39
Change
-$0.04 (-9.30%)
Updated
Nov 15 closing price
YCBD
Price
$0.49
Change
-$0.02 (-3.92%)
Updated
Nov 15 closing price
Ad is loading...

SXTC vs YCBD

Header iconSXTC vs YCBD Comparison
Open Charts SXTC vs YCBDBanner chart's image
China SXT Pharmaceuticals
Price$0.39
Change-$0.04 (-9.30%)
Volume$190.3K
CapitalizationN/A
cbdMD
Price$0.49
Change-$0.02 (-3.92%)
Volume$67.33K
CapitalizationN/A
SXTC vs YCBD Comparison Chart
Loading...
SXTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SXTC vs. YCBD commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXTC is a Sell and YCBD is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (SXTC: $0.39 vs. YCBD: $0.49)
Brand notoriety: SXTC and YCBD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SXTC: 25% vs. YCBD: 49%
Market capitalization -- SXTC: $950.1K vs. YCBD: $2.62M
SXTC [@Pharmaceuticals: Other] is valued at $950.1K. YCBD’s [@Pharmaceuticals: Other] market capitalization is $2.62M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SXTC’s FA Score shows that 0 FA rating(s) are green whileYCBD’s FA Score has 0 green FA rating(s).

  • SXTC’s FA Score: 0 green, 5 red.
  • YCBD’s FA Score: 0 green, 5 red.
According to our system of comparison, YCBD is a better buy in the long-term than SXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SXTC’s TA Score shows that 4 TA indicator(s) are bullish while YCBD’s TA Score has 5 bullish TA indicator(s).

  • SXTC’s TA Score: 4 bullish, 4 bearish.
  • YCBD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both SXTC and YCBD are a good buy in the short-term.

Price Growth

SXTC (@Pharmaceuticals: Other) experienced а -20.68% price change this week, while YCBD (@Pharmaceuticals: Other) price change was +11.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

SXTC is expected to report earnings on Jul 18, 2022.

YCBD is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
YCBD($2.62M) has a higher market cap than SXTC($950K). SXTC has higher P/E ratio than YCBD: SXTC (0.03) vs YCBD (0.00). YCBD YTD gains are higher at: -52.885 vs. SXTC (-90.250). YCBD has higher annual earnings (EBITDA): -3.44M vs. SXTC (-5.36M). YCBD has less debt than SXTC: YCBD (3.37M) vs SXTC (3.76M). YCBD has higher revenues than SXTC: YCBD (23.4M) vs SXTC (1.97M).
SXTCYCBDSXTC / YCBD
Capitalization950K2.62M36%
EBITDA-5.36M-3.44M156%
Gain YTD-90.250-52.885171%
P/E Ratio0.030.001,055%
Revenue1.97M23.4M8%
Total CashN/A1.51M-
Total Debt3.76M3.37M112%
FUNDAMENTALS RATINGS
SXTC vs YCBD: Fundamental Ratings
SXTC
YCBD
OUTLOOK RATING
1..100
6593
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9658
P/E GROWTH RATING
1..100
6474
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

YCBD's Valuation (43) in the Other Consumer Services industry is in the same range as SXTC (73) in the Pharmaceuticals Major industry. This means that YCBD’s stock grew similarly to SXTC’s over the last 12 months.

YCBD's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as SXTC (100) in the Pharmaceuticals Major industry. This means that YCBD’s stock grew similarly to SXTC’s over the last 12 months.

SXTC's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as YCBD (98) in the Other Consumer Services industry. This means that SXTC’s stock grew similarly to YCBD’s over the last 12 months.

YCBD's Price Growth Rating (58) in the Other Consumer Services industry is somewhat better than the same rating for SXTC (96) in the Pharmaceuticals Major industry. This means that YCBD’s stock grew somewhat faster than SXTC’s over the last 12 months.

SXTC's P/E Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as YCBD (74) in the Other Consumer Services industry. This means that SXTC’s stock grew similarly to YCBD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SXTCYCBD
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
SXTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACNT9.950.33
+3.43%
Ascent Industries Co
RERE2.390.01
+0.42%
ATRenew
PRK192.550.11
+0.06%
Park National Corp
WING316.68-13.68
-4.14%
Wingstop
STAF2.27-0.18
-7.35%
Staffing 360 Solutions Inc.

SXTC and

Correlation & Price change

A.I.dvisor tells us that SXTC and SNDL have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTC and SNDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
-10.02%
SNDL - SXTC
28%
Poorly correlated
N/A
ITCI - SXTC
27%
Poorly correlated
-4.80%
LNTH - SXTC
22%
Poorly correlated
-4.96%
EOLS - SXTC
22%
Poorly correlated
+1.94%
RDHL - SXTC
21%
Poorly correlated
+4.29%
More

YCBD and

Correlation & Price change

A.I.dvisor tells us that YCBD and CGC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YCBD and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YCBD
1D Price
Change %
YCBD100%
-3.83%
CGC - YCBD
31%
Poorly correlated
-0.27%
RGEDF - YCBD
28%
Poorly correlated
N/A
ACB - YCBD
23%
Poorly correlated
-3.23%
DRRX - YCBD
23%
Poorly correlated
-9.82%
SXTC - YCBD
23%
Poorly correlated
-10.02%
More